SynthesisFrontiers in oncology2025
Imaging based artificial intelligence for predicting lymph node metastasis in cervical cancer patients: a systematic review and meta-analysis.
Synthesis in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Preoperative assessment of tumor size by MRI and ultrasound in cervical cancer: a large-scale retrospective comparative study.Archives of gynecology and obstetrics · 2026Article
- Article
- Predicting preoperative lymph node status in patients with cervical cancer: development of interpretable machine learning model and support for the biological plausibility.Frontiers in immunology · 2025Article
- Integrated multiparametric ultrasound and biomarker assessment for clinical staging and treatment response prediction in cervical cancer: A single-center retrospective study.Cancer biomarkers : section A of Disease markersArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This meta-analysis was conducted to assess the diagnostic performance of artificial intelligence (AI) based on imaging for detecting lymph node metastasis (LNM) among cervical cancer patients and to compare its performance with that of radiologists. Methods: A comprehensive literature search was conducted across PubMed, Embase, and Web of Science to identify relevant studies published up to October 2024. The search followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses of Diagnostic Test Accuracy (PRISMA-DTA) guidelines. Studies evaluating the accuracy of AI models in detecting LNM in cervical cancer through computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography/computed tomography (PET/CT) were included. Pathology served as the reference standard for validation. A bivariate random-effects model was employed to estimate pooled sensitivity and specificity, both presented alongside 95% confidence intervals (CIs). Bias was assessed with the revised Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. Study heterogeneity was examined through the I Results: A total of 23 studies were included in this meta-analysis. The quality and bias of the included studies were acceptable. However, substantial heterogeneity was observed among the included studies. Internal validation sets comprised 23 studies and 1,490 patients. The pooled sensitivity, specificity, and the area under the curve (AUC) for detecting LNM in cervical cancer were 0.83 (95% CI: 0.78-0.87), 0.78 (95% CI: 0.74-0.82) and 0.87 (95% CI: 0.84-0.90), respectively. External validation sets comprised six studies and 298 patients. The pooled sensitivity, specificity, and AUC for detecting LNM were 0.70 (95% CI: 0.56-0.81), 0.85 (95% CI: 0.66-0.95) and 0.76 (95% CI: 0.72-0.79), respectively. For radiologists, eight studies and 644 patients were included; the pooled sensitivity, specificity, and AUC for detecting LNM were 0.54 (95% CI: 0.42-0.66), 0.79 (95% CI: 0.59-0.91) and 0.65 (95% CI: 0.60-0.69), respectively. Conclusions: Imaging-based AI demonstrates higher diagnostic performance than radiologists. Prospective studies with rigorous standardization as well as further research with external validation datasets, are necessary to confirm the results and assess their practical clinical applicability. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO, identifier CRD42024607074.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.